Applied Healthcare & Health Fitness — PEC2 Adult Primary Care for the Advanced Practice Nurse Version 1
Answer: B
Vasculitis is an uncommon disorder characterized by inflammation mediated by the immune system that destroys blood vessel walls.
Vasculitis refers specifically to the inflammation of blood vessels, which can lead to significant damage and disruption of blood flow. This condition is primarily driven by the immune system attacking the blood vessel walls.
A) Chronic multisystem inflammatory rheumatic disease may cause diverse symptoms such as pain, edema, and rashes
While chronic multisystem inflammatory diseases can present with a variety of symptoms, this option does not specifically define vasculitis. Vasculitis is a specific type of inflammation affecting blood vessels, rather than a general description of rheumatic diseases.
B) An uncommon disorder characterized by inflammation mediated by the immune system that destroys blood vessel walls.
This option accurately describes vasculitis. It highlights the immune-mediated nature of the condition and its specific impact on blood vessel walls, which is the hallmark of vasculitis.
C) A non-autoimmune disease that rarely includes the presence of autoantibodies
This statement is incorrect because vasculitis is typically associated with autoimmune processes, where the immune system mistakenly targets the body's own blood vessels. Therefore, it does not fit the definition of vasculitis.
D) Reversible vasospastic disorder mainly affects the blood flow to the digits
This option refers to a different condition known as vasospasm, which affects blood flow but is not characteristic of vasculitis. Vasculitis involves inflammation and destruction of blood vessel walls rather than merely reversible spasticity.
Conclusion
In summary, the correct answer is option B, as it accurately encapsulates the definition of vasculitis as an immune-mediated inflammation that damages blood vessel walls. Other options either mischaracterize the nature of vasculitis or refer to unrelated conditions, thereby failing to provide an accurate understanding of the term.
Answer: D
Serotonin syndrome
The symptoms presented by the patient, including lower extremity rigidity, agitation, sweating, and a low-grade temperature, align with the characteristics of serotonin syndrome, particularly given the recent use of Venlafaxine, an antidepressant that increases serotonin levels.
A) Psychosis
Psychosis is characterized by a disconnection from reality, including hallucinations and delusions, which are not indicated by the patient's symptoms. The physical symptoms such as rigidity and agitation are more indicative of a physiological reaction rather than a psychological disorder like psychosis.
B) Malignant hyperthermia
Malignant hyperthermia typically occurs in response to certain anesthetic agents and is characterized by muscle rigidity and a rapid increase in body temperature. However, this condition is not related to the medications the patient is taking and does not account for the agitation and sweating observed.
C) Pneumonia
Pneumonia primarily presents with respiratory symptoms such as cough, fever, and difficulty breathing, which are absent in this patient's presentation. While a low-grade fever is noted, the other symptoms do not support a diagnosis of pneumonia.
D) Serotonin syndrome
Serotonin syndrome is a potentially life-threatening condition resulting from excessive serotonergic activity in the nervous system. The combination of the patient's medication history and the symptoms of rigidity, agitation, sweating, and fever strongly suggest this diagnosis, especially following the recent use of Venlafaxine and Diphenhydramine.
Conclusion
Serotonin syndrome is definitively the correct diagnosis due to the specific symptoms and the patient's medication regimen that raises serotonin levels. The other options do not adequately explain the clinical presentation, making them less likely diagnoses in this scenario.
3. Which advice should be given to a patient with moderate persistent asthma?
Answer: C
Cover pillows with plastic dustproof covers to decrease allergen exposure.
To help manage moderate persistent asthma, it is advisable for patients to cover pillows with plastic dustproof covers, as this action reduces exposure to allergens that can exacerbate asthma symptoms.
A) Use albuterol inhaler after physical activity to prevent wheezing.
While using an albuterol inhaler before physical activity can be beneficial for some individuals with asthma to prevent exercise-induced symptoms, it does not address the overall management of moderate persistent asthma, which requires a comprehensive approach that includes minimizing allergen exposure.
B) Cease use of a spacer device with inhaled medications.
Ceasing the use of a spacer device is not advisable as spacers enhance the delivery of inhaled medications to the lungs, ensuring more effective treatment. Patients with moderate persistent asthma should continue using spacers to optimize their medication regimen.
C) Cover pillows with plastic dustproof covers to decrease allergen exposure.
This option is correct as using dustproof covers helps reduce allergen exposure, which is crucial for asthma management. Reducing exposure to potential triggers such as dust mites can lead to better control of asthma symptoms and overall respiratory health.
D) Disregard an asthma action plan with moderate asthma.
Disregarding an asthma action plan is detrimental to asthma management. An action plan is essential for patients with moderate persistent asthma to recognize symptoms, understand medication use, and know when to seek medical attention, thus it should always be adhered to.
Conclusion
The recommendation to cover pillows with plastic dustproof covers is a proactive strategy aimed at decreasing allergen exposure, which is vital for managing moderate persistent asthma effectively. In contrast, the other options either fail to address the critical need for allergen management, suggest harmful practices, or overlook the importance of a structured asthma management plan. Therefore, option C is the most appropriate advice for patients with this condition.
Answer: C
Estimated glomerular filtration rate 30-60 mL/min is the first criteria for referring patients to nephrologists for chronic kidney disease (CKD) management.
Referring patients to nephrologists for chronic kidney disease management is typically based on an estimated glomerular filtration rate (eGFR) of 30-60 mL/min, as this range indicates a moderate reduction in kidney function that requires specialized care.
A) Estimated glomerular filtration rate 120 mL/min
This option reflects normal kidney function and does not indicate a need for nephrology referral. An eGFR of 120 mL/min suggests that the kidneys are functioning well, thus it is not a criterion for CKD management referral.
B) Estimated glomerular filtration rate 30 mL/min
While an eGFR of 30 mL/min denotes severe kidney impairment, it is not the primary threshold for referral. Patients with this level of kidney function are often already considered for nephrology care; however, the more commonly accepted range to initiate referral is 30-60 mL/min.
C) Estimated glomerular filtration rate 30-60 mL/min
This option is correct as it represents the criteria for referring patients to nephrologists for chronic kidney disease management. An eGFR within this range indicates a moderate decline in kidney function, warranting specialized evaluation and management.
D) Estimated glomerular filtration rate >90 mL/min
An eGFR greater than 90 mL/min indicates normal kidney function and does not necessitate a referral to nephrology. Patients in this category typically do not require specialized kidney management.
Conclusion
The correct answer is C, as an estimated glomerular filtration rate of 30-60 mL/min is the recognized criteria for initiating referral to nephrologists for chronic kidney disease management. Options A, B, and D either indicate normal kidney function or do not encapsulate the threshold for referral, thus failing to meet the criteria necessary for specialized care.
Answer: C
You will need annual screening until 15 years after quitting smoking.
The U.S. Preventive Services Task Force (USPSTF) recommends that individuals who have a significant history of smoking, such as this patient, undergo annual lung cancer screening with low-dose computed tomography (LDCT) until 15 years after they have quit smoking.
A) "You will need to be screened if you exhibit respiratory symptoms."
This statement is incorrect as the USPSTF guidelines focus on screening based on smoking history rather than the presence of respiratory symptoms. Screening is recommended for high-risk individuals regardless of symptoms to detect lung cancer at an earlier stage.
B) "You will need an annual chest x-ray screening until age 70."
This option is also incorrect. The USPSTF does not recommend chest x-rays for lung cancer screening; instead, it advocates for low-dose computed tomography (LDCT) as the preferred method for high-risk individuals, particularly those with a history of heavy smoking.
C) "You will need annual screening until 15 years after quitting smoking."
This statement is correct. According to the USPSTF guidelines, individuals aged 50 to 80 with a significant smoking history should receive annual screening for lung cancer with LDCT until 15 years after they have quit smoking, which aligns perfectly with the patient's profile.
D) "You will need to begin screening when you reach the age of 60."
This statement is incorrect since the recommendation is not solely based on age but rather on smoking history and the duration of time since quitting. The guidelines specifically target individuals aged 50 to 80 with a history of heavy smoking, regardless of their current age.
Conclusion
The correct answer is definitive as it aligns with the current USPSTF recommendations, emphasizing the importance of regular screening for lung cancer based on a patient’s smoking history. Other options fail to address the specific guidelines regarding smoking cessation timelines and the method of screening, thereby providing inadequate or incorrect information.
Answer: A
Moving to a private area for the assessment is essential in assessing for intimate partner violence.
This approach allows the patient to feel safe and secure when discussing potentially sensitive issues related to intimate partner violence, fostering an environment conducive to open communication.
A) "Let's move to a private area for the assessment."
This option is correct because it prioritizes the patient's safety and comfort, creating a confidential space where they may feel more at ease to disclose any instances of intimate partner violence. Ensuring privacy can encourage the patient to reveal sensitive information without fear of judgment or repercussions.
B) "Why don't you tell me what really happened?"
This option is incorrect as it may come off as accusatory or confrontational, potentially putting the patient on the defensive. Such an approach could hinder open dialogue and discourage the patient from sharing the truth about their situation.
C) "Let's discuss what occurred with your spouse."
This option is also incorrect since involving the spouse in the discussion could further intimidate the patient or lead them to withhold information. It is crucial to assess the situation without the presence of the partner to ensure the patient feels safe enough to speak freely.
D) "Did anything occur to cause this injury to yourself?"
This option is not the best choice because it places the onus on the patient to explain their injuries in a manner that might imply self-blame. Such phrasing could be distressing and may not effectively elicit information regarding intimate partner violence.
Conclusion
The correct answer, moving to a private area, is vital for creating a safe environment for the patient to discuss their injuries and any potential abuse. In contrast, the other options either risk making the patient uncomfortable or do not provide the necessary privacy, which is crucial for revealing the truth about intimate partner violence. This emphasizes the importance of sensitivity and confidentiality in healthcare settings when addressing such delicate matters.
Answer: A
Noncontrast helical CT scan is the gold standard diagnostic test for detecting renal stones and urinary tract obstructions.
Noncontrast helical CT scans are highly sensitive and specific for detecting renal stones and urinary tract obstructions, making them the preferred diagnostic tool in clinical practice.
A) Noncontrast helical CT scan
This option is correct because noncontrast helical CT scans provide rapid imaging and have a high accuracy for identifying renal stones and obstructions. They can visualize the entire urinary tract and detect even small stones without the use of contrast material, which can be contraindicated in some patients.
B) Intravenous pyelogram
Intravenous pyelogram (IVP) is less commonly used today as it requires contrast injection and is more limited in its ability to detect smaller stones. While IVP can provide information about the urinary tract, it is not as sensitive or quick as a noncontrast helical CT scan.
C) Renal ultrasound
Renal ultrasound is a useful tool for assessing kidney structure and can identify larger stones or obstructions, but it lacks the sensitivity of a noncontrast helical CT scan for detecting smaller stones. It is also operator-dependent, which can affect diagnostic accuracy.
D) Urine culture and sensitivity
Urine culture and sensitivity tests are used to diagnose urinary tract infections but do not provide information about the presence of renal stones or obstructions. Therefore, this option is not relevant to the question regarding the detection of these conditions.
Conclusion
The noncontrast helical CT scan is the definitive gold standard for diagnosing renal stones and urinary tract obstructions due to its high sensitivity and specificity. Other options such as IVP, renal ultrasound, and urine cultures do not match the diagnostic capabilities of a noncontrast helical CT scan, making them less effective for this purpose.
Answer: B
Lyme Disease is the most likely diagnosis for this patient's symptoms.
The presence of a circular rash with a central clearing, known as erythema migrans, along with the patient's recent camping trip in Wisconsin, strongly suggests Lyme Disease as the diagnosis.
A) Ehrlichiosis
Ehrlichiosis typically presents with symptoms such as fever, chills, and headache, but it does not usually cause a characteristic rash like the circular rash described in this case. Additionally, the patient's camping trip aligns more with Lyme Disease, which is endemic in that region.
B) Lyme Disease
Lyme Disease is caused by the Borrelia burgdorferi bacterium, which is transmitted through tick bites, common in areas like Wisconsin. The circular rash with a central clearing is a hallmark sign of Lyme Disease, making this the most likely diagnosis given the patient's symptoms and recent activities.
C) Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever typically presents with a petechial rash and high fever, and it is associated with a more severe clinical course. The rash described in this scenario does not match the classic presentation of Rocky Mountain Spotted Fever, thus making it an unlikely diagnosis.
D) Powassan (POW) virus
Powassan virus infection can cause fever and neurological symptoms; however, it is less common and does not typically present with the characteristic circular rash seen in this patient. Given the context, it is not the most plausible diagnosis.
Conclusion
Lyme Disease is the most fitting diagnosis for this patient due to the specific symptoms of a circular rash with central clearing and the recent camping history in a region where Lyme disease is prevalent. Other options like Ehrlichiosis, Rocky Mountain Spotted Fever, and Powassan virus do not present with the same hallmark rash or relevant exposure history, confirming their unlikelihood as the correct diagnosis.
9. What is the initial treatment for acute adrenal insufficiency?
Answer: C
Transfer immediately to an emergency room
The initial treatment for acute adrenal insufficiency involves transferring the patient immediately to an emergency room. This is crucial for ensuring that the patient receives prompt and appropriate medical intervention to manage their condition effectively.
A) Transfer immediately to a critical care unit
While transferring to a critical care unit may be necessary in severe cases of adrenal insufficiency, the immediate step is to stabilize the patient in an emergency room where they can receive urgent care. Therefore, this option is not the most appropriate initial treatment.
B) Anti-inflammatories and vasopressors
Anti-inflammatories and vasopressors are not the first-line treatments for acute adrenal insufficiency. The primary concern in this scenario is to stabilize the patient and provide immediate access to supportive care, which is best achieved in an emergency room setting rather than through medication alone.
C) Transfer immediately to an emergency room
Transferring the patient to an emergency room is essential for the management of acute adrenal insufficiency. This setting provides immediate access to necessary medical resources and specialized care to effectively address the adrenal crisis.
D) Antipyretics and pain medication
Antipyretics and pain medication may provide symptomatic relief, but they do not address the underlying cause of acute adrenal insufficiency. Therefore, this approach does not represent an appropriate initial treatment strategy, which must focus on urgent medical stabilization.
Conclusion
The correct answer is to transfer immediately to the emergency room, as it allows for quick stabilization and treatment of acute adrenal insufficiency. Other options either delay necessary care or do not adequately address the critical nature of the condition, making them less suitable as initial treatments.
10. What is the initial laboratory test for symptomatic diverticulosis?
Answer: C
Complete blood count and differential is the initial laboratory test for symptomatic diverticulosis.
A complete blood count and differential is crucial for evaluating symptomatic diverticulosis as it helps identify signs of infection or inflammation, which are common in this condition.
A) Basic metabolic panel and enzymes
The basic metabolic panel measures glucose, electrolytes, and kidney function but does not specifically assess signs of diverticulosis or related complications. Therefore, it is not the appropriate initial test for this condition.
B) Coagulation panel
A coagulation panel evaluates blood clotting capabilities and is not relevant for diagnosing or evaluating diverticulosis. This test does not provide information about signs of infection or inflammation associated with diverticulosis.
C) Complete blood count and differential
The complete blood count and differential is vital in assessing for leukocytosis, which may indicate infection due to diverticulitis, a potential complication of diverticulosis. This test provides essential information that guides the clinical management of symptomatic patients.
D) Blood enzyme test
Blood enzyme tests focus on specific organ functions, such as liver or cardiac enzymes, and do not directly address the symptoms or complications associated with diverticulosis. Thus, it is not suitable as an initial test for this condition.
Conclusion
The complete blood count and differential is the most relevant initial laboratory test for symptomatic diverticulosis, as it assists in identifying potential complications like diverticulitis. The other options fail to provide pertinent information regarding the condition's diagnosis or management. Therefore, option C is the definitive correct answer.